February 12, 2019 / 11:13 AM / a month ago

India's Sun Pharma Q3 profit rises nearly four-fold, beats estimate

Feb 12 (Reuters) - Sun Pharmaceutical Industries Ltd , India’s largest drugmaker by market value, posted a nearly four-fold jump in quarterly profit on Tuesday, beating estimates.

Net profit came in at 12.42 billion rupees ($175.45 million) versus 3.22 billion rupees profit last year, the company said here

This was above an average estimate for a profit of 9.86 billion rupees from 16 analysts, Refinitiv Eikon data shows.

Last year in the same quarter the company had a one-time tax expense of 5.13 billion rupees.

Total revenue from operations grew 16.3 percent to 77.40 billion rupees.

$1 = 70.7875 Indian rupees Reporting by Krishna V Kurup in Bengaluru; Editing by David Evans

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below